Liquid chromatography-tandem mass spectrometry for monitoring vitamin D hydroxymetabolites in human aqueous humor
文献情報
Neus Fabregat-Cabello, Pierre Darimont, Loreen Huyghebaert, Pascal Reynier, Caroline Le Goff, Étienne Cavalier
A stable isotope dilution liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) and 25-hydroxyvitamin D3/D2 (25(OH)D3/D2) in human aqueous humor samples from the Eye-D study. Optimum sample preparation is based on simple liquid–liquid extraction (LLE) followed by derivatization with an Amplifex reagent prior to LC-MS/MS in order to enhance analyte sensitivity. The average recoveries for 24,25(OH)2D3 (0.02, 0.05, 0.4 μg L−1), 25(OH)D3 (0.2, 0.5,3.75 μg L−1) and 25(OH)D2 (0.15, 0.4, 3 μg L−1) ranged from 92 to 112 with a coefficient of variance (CV) lower than 15%. The limits of quantitation (LOQs) were from 0.02 μg L−1 (24,25(OH)2D3) to 0.2 μg L−1 (25(OH)D3) using a sample volume of 50 μL. We demonstrated that the present method provides adequate sensitivity, selectivity, accuracy, and robustness to screen for vitamin D metabolites in aqueous humor samples by analyzing five samples which were withdrawn during cataract operation.
関連文献
Phase stability and mechanical properties of tungsten borides from first principles calculations
Jian Meng, Yanming Ma, Zhijian Wu
DOI: 10.1039/C004122J
Comment on “NMR spectroscopic studies of cellobiose solvation in EmimAc aimed to understand the dissolution mechanism of cellulose in ionic liquids” by J. Zhang, H. Zhang, J. Wu, J. Zhang, J. He and J. Xiang, Phys. Chem. Chem. Phys., 2010, 12, 1941
Richard C. Remsing, Igor D. Petrik, Zhiwei Liu, Guillermo Moyna
DOI: 10.1039/C004203J
Photocatalytic disproportionation of nitrite to dinitrogen and nitrate in an aqueous suspension of metal-loaded titanium(iv) oxidenanoparticles
Hiroshi Kominami, Hitoshi Gekko, Keiji Hashimoto
DOI: 10.1039/C0CP00794C
Boron K4 crystal: a stable chiral three-dimensional sp2 network
Jun Dai, Zhenyu Li, Jinlong Yang
DOI: 10.1039/C0CP00735H
Fragment molecular orbital investigation of the role of AMP protonation in firefly luciferase pH-sensitivity
Bruce F. Milne, Fernando Nogueira
DOI: 10.1039/C0CP00932F
NC unit trapped by fullerenes: a density functional theory study on Sc3NC@C2n (2n = 68, 78 and 80)
Zhen Zhou, Ce Hao, Zhanxian Gao, Kai Tan, Xin Lu, Zhongfang Chen
DOI: 10.1039/B923106D
Is the planar hexacoordinate nitrogen molecule NB6− viable?
Chang-bin Shao, Yi-hong Ding
DOI: 10.1039/C0CP00676A
Field-controlled magnetic order with insulator–metal transitions in a periodic Anderson-like organic polymer
L. J. Ding, H. H. Fu
DOI: 10.1039/C0CP00185F
こちらもおすすめ
(S)-四氢呋喃-3-羧酸の物理化学的性質は何ですか?
CAS番号168395-26-4の(S)-四氢呋喃-3-羧酸は、白色の結晶が特徴的な性質を持ちます。分子量は128.08であり、水に溶けやすく、アルコールなど...
塩基性硫黄化合物1,3-ジメチル-1-[5-(三氟甲基)-1,3,4-硫杂环己二酮-2-基]尿素を含む廃棄物はどのように処理すべきですか?
塩基性硫黄化合物1,3-ジメチル-1-[5-(三氟甲基)-1,3,4-硫杂环己二酮-2-基]尿素を含む廃棄物は、専門的な廃棄処理施設で焼却処理を行うべきです。ま...
インドリジン-2-カルボン酸は安全ですか?
インドリジン-2-カルボン酸は一般的に安全ですが、過度に濃い状態では刺激性があります。取り扱いには適切な防護具を使用し、直接触れや吸入を避ける必要があります。
5-甲基-2-(3-ピリジニル)-1,3-テイゾール-4-オールの市場動向や研究トレンドはどうですか?
5-甲基-2-(3-ピリジニル)-1,3-テイゾール-4-オールは、医薬品や農薬、および合成化学の分野において研究が進められています。市場動向としては、化学物質...
4,4',4''-(嘧啶-2,4,6-三基)三苯甲醛はどのように保存すればよいですか?
4,4',4''-(嘧啶-2,4,6-三基)三苯甲醛は、密閉容器に保管し、避けておくことが重要です。室温で保管し、直射日光を避けてください。
(3aR)-1,3,3-トリフェニルテトラヒドロ-3H-ピロロ[1,2-c][1,3,2]-オキザボロロールについて、適用される法規ガイドラインは何ですか?
(3aR)-1,3,3-トリフェニルテトラヒドロ-3H-ピロロ[1,2-c][1,3,2]-オキザボロロールは、GHS(国際危険物識別ルール)の分類が適用されま...
6-(4-氯苯氧基)吡啶-3-胺の代替品はありますか?
6-(4-氯苯氧基)吡啶-3-胺の代替品としては、他の芳香族アミン化合物や類似の除草剤が考えられます。ただし、他の化合物と同様に、代替品の選択には安全性と効果性...
3-フェニル-3,4-ジヒドロ-2H-1,4-ベンゾキサジンを取り扱う際の実験室安全事項は何ですか?
3-フェニル-3,4-ジヒドロ-2H-1,4-ベンゾキサジンを取り扱う際は、防塵マスク、ゴーグル、ゴム手袋を使用し、ドラフトチャンバー内で作業することを推奨しま...
掲載誌
Analytical Methods

Analytical Methods welcomes early applications of new analytical and bioanalytical methods and technology demonstrating the potential for societal impact. We require that methods and technology reported in the journal are sufficiently innovative, robust, accurate, and compared to other available methods for the intended application. Developments with interdisciplinary approaches are particularly welcome. Systems should be proven with suitably complex and analytically challenging samples. We encourage developments within, but not limited to, the following technologies and applications: global health, point-of-care and molecular diagnostics biosensors and bioengineering drug development and pharmaceutical analysis applied microfluidics and nanotechnology omics studies, such as proteomics, metabolomics or glycomics environmental, agricultural and food science neuroscience biochemical and clinical analysis forensic analysis industrial process and method development














